Characterization of Remission in Patients with Psoriatic Arthritis Treated with Upadacitinib: Post-hoc Analysis from Two Phase 3 Trials

被引：0
|
作者：
Mease, Philip [1 ]
Kavanaugh, Arthur [2 ]
Gladman, Dafna [3 ]
FitzGerald, Oliver [4 ]
Soriano, Enrique [5 ,6 ]
Nash, Peter [7 ]
Feng, Dai [8 ]
Lertratanakul, Apinya [8 ]
Douglas, Kevin [8 ]
Lippe, Ralph [9 ]
Gossec, Laure [10 ,11 ]
机构：
[1] Seattle Rheumatol Associates PLLC, Seattle, WA USA
[2] Univ Calif San Diego, Sch Med, Div Rheumatol Allergy & Immunol, San Diego, CA 92103 USA
[3] Toronto Western Hosp, Krembil Res Inst, Toronto, ON, Canada
[4] Univ Coll Dublin, Conway Inst Biomol Res, Dublin, Ireland
[5] Hosp Italiano Buenos Aires, Escuela Med, Inst Univ, Dept Publ Hlth, Buenos Aires, DF, Argentina
[6] Hosp Italiano Buenos Aires, Internal Med Serv, Rheumatol Unit, Buenos Aires, DF, Argentina
[7] Griffith Univ, Sch Med, Brisbane, Qld, Australia
[8] AbbVie Inc, N Chicago, IL USA
[9] AbbVie Deutschland GmbH & Co KG, Wiesbaden, Germany
[10] Sorbonne Univ, Paris, France
[11] Hop Univ Pitie Salpetriere, Paris, France
来源：
ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷
关键词：
INADEQUATE RESPONSE; DOUBLE-BLIND; EFFICACY; SAFETY;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1355
引用
收藏
页数：3
相关论文
共 50 条
  • [1] CHARACTERIZATION OF REMISSION IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH UPADACITINIB: POST-HOC ANALYSIS FROM TWO PHASE 3 TRIALS
    Mease, P. J.
    Kavanaugh, A.
    Gladman, D. D.
    Fitzgerald, O.
    Soriano, E.
    Nash, P.
    Feng, D.
    Lertratanakul, A.
    Douglas, K.
    Lippe, R.
    Gossec, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1294 - 1295
  • [2] Characterization of Remission in Patients with Psoriatic Arthritis Treated with Upadacitinib: Post-hoc Analysis from Two Phase 3 Trials
    Gladman, Dafna
    Kavanaugh, Arthur
    FitzGerald, Oliver
    Soriano, Enrique
    Nash, Peter
    Feng, Dai
    Lertratanakul, Apinya
    Douglas, Kevin
    Lippe, Ralph
    Gossec, Laure
    Mease, Philip
    [J]. JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 1115 - 1115
  • [3] CHARACTERIZATION OF REMISSION IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH UPADACITINIB: POST-HOC ANALYSIS FROM TWO PHASE 3 TRIALS
    Mease, Philip
    Kavanaugh, Arthur
    Gladman, Dafna
    Fitzgerald, Oliver
    Soriano, Enrique
    Nash, Peter
    Feng, Dai
    Lertratanakul, Apinva
    Douglas, Kevin
    Lippe, Ralph
    Gossec, Laura
    [J]. INTERNAL MEDICINE JOURNAL, 2021, 51 : 45 - 45
  • [4] Evaluating the efficacy of upadacitinib in patients with moderate rheumatoid arthritis: a post-hoc analysis of the SELECT phase 3 trials
    Conaghan, Philip G.
    Pavelka, Karel
    Hsieh, Song-Chou
    Bonnington, Terri-Leigh
    Kent, Toby C.
    Marchbank, Katie
    Edwards, Christopher J.
    [J]. RHEUMATOLOGY ADVANCES IN PRACTICE, 2022, 7 (01)
  • [5] Comparison of Composite Indices for Disease Activity in Patients with Psoriatic Arthritis Treated with Upadacitinib: A Post-Hoc Analysis from SELECT-PsA 1
    Smolen, Josef
    Lubrano, Ennio
    Kishimoto, Mitsumasa
    Balanescu, Andra R.
    Strand, Vibeke
    Gao, Tianming
    Vranich, Nancy
    Lippe, Ralph
    Tillett, William
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3790 - 3792
  • [6] Upadacitinib Effects on Entheseal Domain in Psoriatic Arthritis Patients - a Pooled "post-hoc" Analysis from Two Phase III Studies (Select PsA 1 and 2)
    Cantini, Fabrizio
    Marchesoni, Antonio
    Marando, Francesca
    Gualberti, Giuliana
    Novelli, Lucia
    Curradi, Giacomo
    McDearmon--Blondell, Erin
    Gao, Tianming
    Salvarani, Carlo
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2789 - 2791
  • [7] Safety Profile of Upadacitinib in Psoriatic Arthritis: Integrated Analysis from Two Phase 3 Trials
    Burmester, Gerd
    Winthrop, Kevin
    Nash, Peter
    Goupille, Philippe
    Azevedo, Valderilio F.
    Salvarani, Carlo
    McCaskill, Reva M.
    Liu, John
    Pierre-Louis, Bosny J.
    Anderson, Jaclyn K.
    Ruderman, Eric
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [8] TOFACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS AND METABOLIC SYNDROME: A POST-HOC ANALYSIS OF PHASE 3 STUDIES
    Ritchlin, C.
    Giles, J.
    Ogdie, A.
    Gomez-Reino, J.
    Stockert, L.
    Young, P.
    Wang, C.
    Romero, A. B.
    Kudlacz, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1023 - 1023
  • [9] COMPARISON OF COMPOSITE INDICES FOR DISEASE ACTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH UPADACITINIB: A POST-HOC ANALYSIS FROM SELECT-PSA 1
    Smolen, J. S.
    Lubrano, E.
    Kishimoto, M.
    Balanescu, A.
    Strand, V.
    Gao, T.
    Vranich, N.
    Lippe, R.
    Tillett, W.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 824 - 824
  • [10] SAFETY PROFILE OF UPADACITINIB IN PSORIATIC ARTHRITIS: INTEGRATED ANALYSIS FROM TWO PHASE 3 TRIALS
    Burmester, Gerd
    Winthrop, Kevin
    Nash, Peter
    Goupille, Philippe
    Azevedo, Valderilio F.
    Salvarani, Carlo
    McCaskill, Reva M.
    Liu, John
    Pierre-Louis, Bosny J.
    Anderson, Jaclyn K.
    Ruderman, Eric
    [J]. INTERNAL MEDICINE JOURNAL, 2021, 51 : 46 - 46
12345